CREB3L2 Antibody [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-97960C
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry-Paraffin
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Produced in rabbits immunized with E. coli-derived Human CREB3L2 fragment.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for CREB3L2 Antibody [DyLight 650]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CREB3L2
Alternate Names
basic transcription factor 2, BBF2 human homolog on chromosome 7, BBF2H7TCAG_1951439, B-ZIB transcription factor, cAMP responsive element binding protein 3-like 2, cAMP-responsive element-binding protein 3-like protein 2, cyclic AMP-responsive element-binding protein 3-like protein 2, FUS/BBF2H7 protein, MGC131709, MGC71006
Gene Symbol
CREB3L2
Additional CREB3L2 Products
Product Documents for CREB3L2 Antibody [DyLight 650]
Product Specific Notices for CREB3L2 Antibody [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...